Blood Flow Mismatch in Pancreatic Cancers Camp Lejeune NC

Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness. The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people.

Scott Lee Sailer, MD
(919) 854-4588
300 Ashville Ave Ste 110
Cary, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Harvard Med Sch, Boston Ma 02115
Graduation Year: 1984

Data Provided by:
Noel Anderson Brownlee, MD, PHD
(336) 806-0683
Medical Center Blvd,
Winston Salem, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Louis F Diehl, MD
(919) 684-8964
Box 3872,
Durham, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Georgetown Univ Sch Of Med, Washington Dc 20007
Graduation Year: 1975

Data Provided by:
Jeffrey Bryan VanDeusen
(919) 684-8111
Duke University Medical Ctr
Durham, NC
Specialty
Hematology / Oncology

Data Provided by:
Rosa Elena Cuenca, MD
(252) 744-5418
600 Moye Blvd
Greenville, NC
Specialties
Oncology (Cancer)
Gender
Female
Languages
Italian, Spanish
Education
Medical School: East Carolina Univ Sch Of Med, Greenville Nc 27858
Graduation Year: 1986
Hospital
Hospital: Pitt County Memorial Hospital, Greenville, Nc
Group Practice: Ecu Physicians Brody School Of Medicine

Data Provided by:
Kevin A Schulman, MD
(919) 668-8101
PO Box 17969
Durham, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Roger F Anderson Jr, MD
(919) 784-3018
4420 Lake Boone Trl
Raleigh, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Duke Univ Sch Of Med, Durham Nc 27710
Graduation Year: 1981
Hospital
Hospital: Rex Healthcare, Raleigh, Nc; Wake Med Ctr, Raleigh, Nc
Group Practice: Triangle Radiation Oncology Services Inc

Data Provided by:
Antonius Arthur Miller
(336) 716-2255
Medical Center Blvd
Winston Salem, NC
Specialty
Hematology / Oncology

Data Provided by:
Susan Whelen Schaffer, DO
(910) 291-7630
500 E Lauchwood Dr
Laurinburg, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Philadelphia Coll Of Osteo Med, Philadelphia Pa 19131
Graduation Year: 1995

Data Provided by:
Lothar H Finke, MD
(919) 401-7108
3211 Shannon Rd
Durham, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Data Provided by:

Blood Flow Mismatch in Pancreatic Cancers

Provided By:

WEDNESDAY, Aug. 26 (HealthDay News) -- Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness.

The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people. The researchers noted that blood flow in malignant tumors was 60 percent less than in normal pancreatic tissue.

The findings may help explain why many pancreatic cancer patients have a poor response to radiation treatment and chemotherapy, the study authors noted in their report published Aug. 25 in Clinical Cancer Research.

"Imaging of several of these tumor parameters might be important for the planning and success of [cancer] therapies," study author Dr. Gaber Komar, research fellow at the Turku PET Center, said in a news release from the American Association for Cancer Research. "We believe that a better understanding of these mechanisms may help overcome the general treatment resistance of pancreatic cancer."

"This study confirms that blood flow metabolism mismatch exists in pancreatic tumors, similar to other cancers such as breast and lung cancers, and predicts poor patient outcome," Dr. David Mankoff, a professor of radiology, medicine and bioengineering at the University of Washington in Seattle, said in the news release.

"A blood flow metabolism mismatch by PET appears to be associated with cancer aggressiveness and treatment resistance. We've only recently recognized this pattern as a result of advantages in functional imaging methods," added Mankoff.

More information

The American Cancer Society has more about pancreatic cancer.

SOURCE: American Association for Cancer Research, news release, Aug. 25, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com